CORDIS
EU research results

CORDIS

English EN
Pan-European network for the study and clinical management of drug resistant tuberculosis

Pan-European network for the study and clinical management of drug resistant tuberculosis

Objective

This proposal will establish an integrated and synergistic network to address the challenge of multiple drug resistant tuberculosis (MDR-TB) facing the EU. The objective will be attained through the establishment of a European consortium of expert partners with extensive experience in the conduct of basic and clinical research relating to MDR-TB, TB control and epidemiology. This Consortium will achieve this by: • Conducting an extensive and focused programme of basic/clinical research to improve the diagnosis and management of MDR-TB • Develop a broad training curriculum leading to the creation of a new generation of scientists and clinicians expert in the management of drug resistant TB • Create field sites across the EU with the capacity for evaluating new diagnostic systems and novel drug therapies on behalf of European industry and government • Establish a unified and robust quality assurance mechanism for the accurate and rapid diagnosis of drug resistance and develop appropriate safety standard for European health care workers • Improving our understanding of the transmission of MDR-TB at the molecular level and host-related risk factors for its development, • The Consortium will disseminate its findings and analyses widely to the benefit of specialists, general health care staff, EU governments, NGOs and health policy makers. This will provide researchers and clinicians with appropriate knowledge and improved tools to fight MDR-TB, and assist European industry in the development of new diagnostics and treatments. Consortium outputs will assist governments in the development and implementation of appropriate health and social policies to limit and control the spread of MDR-TB within the member states of the EU. Internationally, these objectives will assist countries bordering the EU and international agencies such as the WHO and ECDC in reducing the impact of drug resistance.

Coordinator

UNIVERSITA VITA-SALUTE SAN RAFFAELE

Address

Via Olgettina 58
20132 Milano

Italy

Activity type

Higher or Secondary Education Establishments

EU Contribution

€ 979 381

Administrative Contact

Raffaella Voltolini (Dr.)

Participants (31)

Sort alphabetically

Sort by EU Contribution

Expand all

National Tuberculosis and Infectious Diseases University Hospital

Lithuania

SMITTSKYDDSINSTITUTET

Sweden

QUEEN MARY UNIVERSITY OF LONDON

United Kingdom

EU Contribution

€ 1 677 700

FORSCHUNGSZENTRUM BORSTEL

Germany

EU Contribution

€ 1 740 747

FONDAZIONE SALVATORE MAUGERI CLINICA DEL LAVORO E DELLA RIABILITAZIONE

Italy

EU Contribution

€ 373 096

AZIENDA OSPEDALIERA SAN GERARDO DI MONZA

Italy

EU Contribution

€ 383 030

EUROPEAN RESPIRATORY SOCIETY

Switzerland

EU Contribution

€ 743 960

Foundation for Innovative New Diagnostics

Switzerland

EU Contribution

€ 310 909

FOLKHALSOMYNDIGHETEN

Sweden

EU Contribution

€ 548 960

STATENS SERUM INSTITUT

Denmark

EU Contribution

€ 145 080

HRVATSKI ZAVOD ZA JAVNO ZDRAVSTVO

Croatia

EU Contribution

€ 51 000

UNIVERSITA DEGLI STUDI DI SIENA

Italy

EU Contribution

€ 400 700

Hain Lifescience GmbH

Germany

EU Contribution

€ 241 100

LATVIJAS INFEKTOLOGIJAS CENTRS (INFECTOLOGY CENTER OF LATVIA)

Latvia

EU Contribution

€ 273 926

MONTESSORI GUIDO

Italy

EU Contribution

€ 164 208

SIHTASUTUS TARTU ULIKOOLI KLIINIKUM

Estonia

EU Contribution

€ 183 800

VIESOJI ISTAIGA VILNIAUS UNIVERSITETO LIGONINE SANTAROS KLINIKOS

Lithuania

EU Contribution

€ 567 725

VILNIAUS UNIVERSITETAS

Lithuania

EU Contribution

€ 104 400

FOLKEHELSEINSTITUTTET

Norway

EU Contribution

€ 71 954

UNIVERZITETNA KLINIKA ZA PLJUCNE BOLEZNI IN ALERGIJO GOLNIK

Slovenia

EU Contribution

€ 52 320

PRINS LEOPOLD INSTITUUT VOOR TROPISCHE GENEESKUNDE

Belgium

EU Contribution

€ 139 500

SPITALUL DE PNEUMOFTIZIOLOGIE BRASOV

Romania

EU Contribution

€ 172 200

"INSTITUTUL DE PNEUMOFTIZIOLOGIE ""MARIUS NASTA"""

Romania

EU Contribution

€ 97 129

INSTITUT PASTEUR DE LILLE FONDATION

France

EU Contribution

€ 211 989

TERVEYDEN JA HYVINVOINNIN LAITOS

Finland

EU Contribution

€ 63 000

INSTITUT SCIENTIFIQUE DE SANTE PUBLIQUE

Belgium

EU Contribution

€ 139 288

INSTYTUT GRUZLICY I CHOROB PLUC

Poland

EU Contribution

€ 46 320

University of Medicine and Dentistry of New Jersey

United States

EU Contribution

€ 371 995

RIGAS AUSTRUMU KLINISKA UNIVERSITATES SLIMNICA SIA

Latvia

EU Contribution

€ 47 384

Fondazione Centro San Raffaele

Italy

EU Contribution

€ 695 469

Rutgers, The State University of New Jersey - RBHS

United States

Project information

Grant agreement ID: 223681

Status

Closed project

  • Start date

    1 January 2009

  • End date

    30 June 2014

Funded under:

FP7-HEALTH

  • Overall budget:

    € 14 115 409,80

  • EU contribution

    € 10 998 270

Coordinated by:

UNIVERSITA VITA-SALUTE SAN RAFFAELE

Italy